Back to Stakeholders
Categories
1 domain / 2 areas / 2 specializations
Damona Pharmaceuticals
Data updated
Enterprise Intelligence
Quarterly psychedelic drug-development briefing
Compare indication activity, programme milestones, competitive intensity, and near-term catalysts. Q2 includes quarter-over-quarter changes against the published Q1 baseline.
Damona Pharmaceuticals is a biotechnology company developing small-molecule therapeutics for the cognitive deficits associated with depression and diseases of ageing. It raised a US$5.5 million seed round in 2022, co-led by the psychedelic-sector investor Noetic Fund.
Ecosystem
1 connectionInvestors
Quick Facts
- Website
- Visit